PRINCIPIA BIOPHARMA INC.: income_tax_expense
| Value | {"amount": 0, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} |
|---|---|
| Period | 2020-04-01 – 2020-06-30 |
| Status | current |
| Entity | PRINCIPIA BIOPHARMA INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/756bb05e-5142-4f9e-b71c-d7dbcee93ba5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-037804 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510487/income-tax-expense/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/756bb05e-5142-4f9e-b71c-d7dbcee93ba5
History
- no predecessors — first report